DE2657292A1 - Verfahren zur schwangerschaftsbestimmung und dafuer verwendbare mehrkomponentenpackung - Google Patents
Verfahren zur schwangerschaftsbestimmung und dafuer verwendbare mehrkomponentenpackungInfo
- Publication number
- DE2657292A1 DE2657292A1 DE19762657292 DE2657292A DE2657292A1 DE 2657292 A1 DE2657292 A1 DE 2657292A1 DE 19762657292 DE19762657292 DE 19762657292 DE 2657292 A DE2657292 A DE 2657292A DE 2657292 A1 DE2657292 A1 DE 2657292A1
- Authority
- DE
- Germany
- Prior art keywords
- hcg
- igg
- mixed
- enzyme
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 17
- 230000035935 pregnancy Effects 0.000 title description 5
- 238000004806 packaging method and process Methods 0.000 title 1
- 239000000243 solution Substances 0.000 claims description 28
- 102000004190 Enzymes Human genes 0.000 claims description 21
- 108090000790 Enzymes Proteins 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 15
- 210000001124 body fluid Anatomy 0.000 claims description 6
- 239000010839 body fluid Substances 0.000 claims description 6
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 108010074605 gamma-Globulins Proteins 0.000 claims description 3
- 210000002700 urine Anatomy 0.000 claims description 3
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 108010044091 Globulins Proteins 0.000 claims 1
- 102000006395 Globulins Human genes 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 18
- 229940088598 enzyme Drugs 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- ABJNSVIERCQTTE-UHFFFAOYSA-N 2-fluoro-1,3-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC([N+]([O-])=O)=C1F ABJNSVIERCQTTE-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical group C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 229940098197 human immunoglobulin g Drugs 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL48741A IL48741A (en) | 1975-12-26 | 1975-12-26 | Method for the determination of pregnancy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2657292A1 true DE2657292A1 (de) | 1977-07-14 |
Family
ID=11048617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19762657292 Pending DE2657292A1 (de) | 1975-12-26 | 1976-12-17 | Verfahren zur schwangerschaftsbestimmung und dafuer verwendbare mehrkomponentenpackung |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5282892A (enExample) |
| AT (1) | AT352904B (enExample) |
| AU (1) | AU2049576A (enExample) |
| BE (1) | BE849667A (enExample) |
| DE (1) | DE2657292A1 (enExample) |
| ES (1) | ES454542A1 (enExample) |
| FI (1) | FI763647A7 (enExample) |
| FR (1) | FR2336113A1 (enExample) |
| GB (1) | GB1563299A (enExample) |
| IL (1) | IL48741A (enExample) |
| IT (1) | IT1068738B (enExample) |
| NL (1) | NL7614359A (enExample) |
| SE (1) | SE7614387L (enExample) |
| ZA (1) | ZA767607B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8307897A1 (es) * | 1981-04-13 | 1983-08-01 | Hoechst Co American | Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo. |
| IL63855A (en) * | 1981-09-16 | 1984-10-31 | Teva Pharma | Method and kit for detecting pregnancy |
| US4419453A (en) | 1981-09-28 | 1983-12-06 | The Dow Chemical Company | Immunological agglutination assays with dyed or colored latex and kits |
| US4543339A (en) * | 1982-03-16 | 1985-09-24 | Oneill Christopher | Early pregnancy detection by detecting enhanced blood platelet activation |
| US4503143A (en) * | 1982-08-20 | 1985-03-05 | Btc Diagnostics Limited Partnership | Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen |
| EP0262119A1 (en) * | 1985-03-12 | 1988-04-06 | University Of Queensland | Method for detecting early pregnancy factor (epf) in mammals, purifying epf and method for producing a monoclonal antibody |
| JPS6228666A (ja) * | 1985-07-29 | 1987-02-06 | モダン・ダイアグノステイツクス・インコ−ポレ−テツド | 生物学的試料中の抗原及び抗体検出法及び検出用支持体 |
| CA1337394C (en) * | 1987-11-17 | 1995-10-24 | Nelson N. H. Teng | Vaginal sample test and reagents |
| US7034120B2 (en) | 1999-02-02 | 2006-04-25 | Edp Biotech Corporation, Inc. | Method and apparatus for detecting conception in animals |
-
1975
- 1975-12-26 IL IL48741A patent/IL48741A/xx unknown
-
1976
- 1976-12-13 AU AU20495/76A patent/AU2049576A/en not_active Expired
- 1976-12-15 JP JP15067576A patent/JPS5282892A/ja active Pending
- 1976-12-17 DE DE19762657292 patent/DE2657292A1/de active Pending
- 1976-12-20 FR FR7638333A patent/FR2336113A1/fr not_active Withdrawn
- 1976-12-20 FI FI763647A patent/FI763647A7/fi not_active Application Discontinuation
- 1976-12-21 BE BE173475A patent/BE849667A/xx unknown
- 1976-12-21 SE SE7614387A patent/SE7614387L/xx unknown
- 1976-12-21 IT IT70054/76A patent/IT1068738B/it active
- 1976-12-21 GB GB53444/76A patent/GB1563299A/en not_active Expired
- 1976-12-22 ZA ZA767607A patent/ZA767607B/xx unknown
- 1976-12-23 ES ES454542A patent/ES454542A1/es not_active Expired
- 1976-12-23 AT AT962176A patent/AT352904B/de not_active IP Right Cessation
- 1976-12-23 NL NL7614359A patent/NL7614359A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES454542A1 (es) | 1978-04-01 |
| AU2049576A (en) | 1978-06-22 |
| BE849667A (fr) | 1977-06-21 |
| IT1068738B (it) | 1985-03-21 |
| NL7614359A (nl) | 1977-06-28 |
| FI763647A7 (enExample) | 1977-06-27 |
| IL48741A0 (en) | 1976-02-29 |
| ZA767607B (en) | 1977-11-30 |
| FR2336113A1 (fr) | 1977-07-22 |
| ATA962176A (de) | 1979-03-15 |
| SE7614387L (sv) | 1977-06-27 |
| GB1563299A (en) | 1980-03-26 |
| IL48741A (en) | 1979-07-25 |
| AT352904B (de) | 1979-10-10 |
| JPS5282892A (en) | 1977-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH645465A5 (de) | Immunbiologisches verfahren zur quantitativen bestimmung von haptenen und testausruestung zur durchfuehrung des verfahrens. | |
| DE3650513T2 (de) | Verzögerter immunologischer Test in fester Phase | |
| DE2600465C3 (de) | Verfahren zur radioimmunologischen Bestimmung von Östrogenen | |
| DE2743444A1 (de) | Immunchemisches messverfahren | |
| DE2953449A1 (de) | Verfahren und ausruestung fuer die enzym-immunoassay von biologischen substanzen | |
| DE2164768B2 (de) | Verfahren zum nachweis und zur bestimmung einer komponente der reaktion zwischen spezifischen bindeproteinen und bindefaehigen substanzen | |
| DE2206103A1 (de) | Verfahren zum Nachweisen und Bestimmen einer Komponente der Reaktion zwischen spezifisch bindenden Proteinen und den Substanzen, die von diesen Proteinen spezifisch gebunden werden | |
| EP0089008A2 (de) | Hochspezifisches Antiserum gegen Prokollagen-Peptid Col 1 (Typ III) und Prokollagen-Peptid (Typ III), seine Herstellung und Verwendung. | |
| CH658131A5 (de) | Reagenz und verfahren fuer immunologische analyse. | |
| DE69124511T2 (de) | Verfahren für den nachweis und/oder die bestimmung von hormonen | |
| DE2657292A1 (de) | Verfahren zur schwangerschaftsbestimmung und dafuer verwendbare mehrkomponentenpackung | |
| DE4328070C1 (de) | Verfahren zur Bestimmung eines Analyten in einem Volumen einer flüssigen Probe sowie seine Anwendung zur Bestimmung von anti-TSH-Rezeptor-Autoantikörpern in einem Patientenserum | |
| DE3800048A1 (de) | Verfahren zur bestimmung eines antikoerpers in menschlichen koerperfluessigkeiten | |
| DE3882727T2 (de) | Mycoplasma-Membran-Antigene und ihre Verwendung. | |
| DE2615092A1 (de) | Verfahren zur quantitativen bestimmung von antigenen substanzen und testpackung zur durchfuehrung des verfahrens | |
| DE69304528T2 (de) | Verfahren zur bestimmung der menge eines schilddrüsenhormon-liganden in einer biologischen flüssigkeit und satz zur durchführung dieses verfahrens | |
| DE2713369C2 (de) | Nicht löslicher Antikörper, Verfahren zu seiner Herstellung und seine Verwendung im Analysenbesteck für den Enzymimmunassay oder Radioimmunassay | |
| DE3500190A1 (de) | Verbesserte testzusammensetzungen, verfahren zu ihrer herstellung und ihre anwendung in testverfahren | |
| EP0190765B1 (de) | Verfahren zur Bestimmung der Bindungskapazität des Thyroxin bindenden Globulins | |
| DE3887727T2 (de) | Partikelstabilisierte Epitope zur Standardisierung und Kontrolle von Immuntests. | |
| DE2825650C3 (de) | Verfahren zur Bestimmung des Thyroxin-bindungsindex im Serum | |
| DE2537275C3 (de) | Immunchemisches Verfahren zur Bestimmung von Antigenen oder Antikörpern in biologischen Flüssigkeiten | |
| DE2916783C3 (de) | Verfahren zur immunologischen Bestimmung einer Gallensäure oder ihres Konjugats | |
| DE3546014A1 (de) | Verfahren zur bestimmung der bindungskapazitaet des thyroxin bindenden tbg | |
| EP0345732A2 (de) | Verfahren zur Bestimmung eines Antikörpertiters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHJ | Non-payment of the annual fee |